Bioinspired Approach to Sepsis Therapy

5,534 views

|

January 23, 2015

  • Share
  • Wyss Institute Founding Director Don Ingber, Senior Staff Scientist Michael Super and Technology Development Fellow Joo Kang explain how they engineered the Mannose-binding lectin (MBL) protein to bind to a wide range of sepsis-causing pathogens and then safely remove the pathogens from the bloodstream using a novel microfluidic spleen-like device.

    More information: http://wyss.harvard.edu/viewpressrelease/166/bloodcleansing-biospleen-device-developed-for-sepsis-therapy

    BiopharmaDrug DiscoveryMicrobiologyMicrofluidics
    Playlists featuring Wyss Institute for Biologically Inspired Engineering at Harvard University

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.